Comparison Chart Ernexa Therapeutics Inc.

Stocks

ERNA

US1140824079

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
1.970 ^USD	-6.64%		-4.60%	-93.43%

10-22	Ernexa Therapeutics Highlights ERNA-101?s Path Toward The Clinic And Differentiated Cell Therapy Platform In New What This Means Segment	CI
10-06	Ernexa Therapeutics Announces ERNA-101 Preclinical Data Selected For Flash Talk Presentation At Nature Conferences? Next-Generation Cancer Therapeutics Meeting Co-Hosted By MD Anderson Cancer Center	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ERNEXA THERAPEUTICS INC.	Other Biotechnology & Medical Research	-6.64%	-4.60%	-93.43%	-95.57%	-100.00%	3.22M